| 1. Groh V, Li YQ, Cioca D, et al. Efficient cross-priming of tumor antigen-specific T cells by dendritic cells sensitized with diverse anti-MICA opsonized tumor cells［J］. Proc Natl Acade Sci USA, 2005, 102(18): 6464-6466. 2. Sun D, Wang X, Zhang H, MMP9 mediates MICA shedding in human osteosarcomas ［J］. Cell Biol Int. 2011; 35 (6): 569-74. 3. Claudia Muratori, Luca Tamagnone. Semaphorin Signals Tweaking the Tumor Microenvironment［J］. Advances in Cancer Research, 2012；114：59-85. 4. Bin-Zhi Qian, Jeffrey W. Pollard. Macrophage Diversity Enhances Tumor Progression and Metastasis［J］. Cell, 2010; 141(1): 39–51. 5. Jiang X, Huang JF, Huo Z, et al. Elevation of soluble major histocompatibility complex class I related chain A protein in malignant and infectious diseases in Chinese patients. BMC Immunol. 2012; 26(13): 62. 6. Holdenrieder S, Stieber P, Peterfi A, et al. Soluble MICA in malignant diseases. Int J Cancer. 2006; 118(3):684-7. 7. Ganea E，Trifan M，Laslo AC，et a1．Matrix metalloproteinases: useful and deleterious［J］．Biochem Soc Trans，2007，35(4) ：689. 8. Meyer E，Vollmer JV，Bovey R，et a1．Matrix metalloproteinase-9 and 10 inhibit protein kinase C-potentiated，p53-mediated apoptosis［J］．Cancer Res，2005，65(10)：4261. 9. Li CY, Yuan P, Lin SS, et al. Matrix metalloproteinase 9 expression and prognosis in colorectal cancer: a meta-analysis. Tumour Biol. 2013; 34 (2):735-41. 10. Lee BK, Kim MJ, Jang HS, et al. A high concentration of MMP-2/gelatinase A and MMP-9/gelatinase B reduce NK cell-mediated cytotoxicity against an oral squamous cell carcinoma cell line. In Vivo. 2008; 22(5): 593-7. |
